Skip to content

Contact +44 (0) 20 7060 7474 email us

Boehringer Ingelheim

Flomax Case Study

Evolving Disease State Awareness to Succeed with New Method of Action

Publication Date July 2008
Publisher Best Practices LLC
Product Type Report
Pages 54
ISBN Number not applicable
Product Code BPC00014

Price

£2,110.00
approximately: $3,195 | €2,355

print

Buy Now

Order above formats by FAX

Order by Fax

Summary

This case study reviews the strategy and tactics utilized by Boehringer-Ingelheim for the BPH (Benign Prostatic Hyperplasia) indicated product, Flomax/Tamsulosin, to differentiate the product and to boost disease awareness to expand the product market. By carving out a niche as a BPH-specific drug and motivating a large untapped patient pool through multiple communication tactics, Flomax achieved blockbuster status. Executives and managers can use this research to gain insights into methods for differentiating a product and creating effective communication tactics to boost awareness and sales of a new product.

Contents

  • Executive Summary
    • Rationale for Alpha1 Blocker/Flomax Analog
    • Flomax Market Entry
    • Findings: Flomax Market-Entry Insights Are Broad Reaching
    • Flomax Commercialization Timeline
  • Market Entry Strategy
    • Market Entry Strategies Cover Basics plus Personalize Condition
  • Leading with Science
    • Anchor Brand Positioning in Science, Safety & Unmet Need
    • Build upon The Scientific Edifices That Precede Your Drug
    • Earlier Achievements Can Help Catapult The New Product
    • to Market Leadership
    • Use New Science to Break Old Paradigms
  • Product Positioning
    • Position The New Product to Reflect Total Cost Benefits
    • First Approved Alpha Blocker Positioned as Less Risky
    • Differentiate through Improved Mechanism of Action
    • Develop Compelling Brand Promise around New Benefit
    • Extend Sales & Marketing Reach & Expertise with Partnerships
  • Disease Awareness
    • Leverage Market Research to Motivate Untreated Patients
    • Early Successive Generation Must Hit A Higher Standard
    • Use Multiple Communication Channels to Prepare Medical Market
    • Let Kols Lead The Way to A New Paradigm
    • Expand & Vary Key Messages to Physicians over Time
    • Segment Physician Message to Drive Brand Momentum
    • Expedite Change by Providing Useful Diagnostic Tools
    • Use Professional Guidelines to Elevate Drug's Role in Treatment
  • Patient Communications
    • Motivate Men to Seek ""one Week"" Improvement in Quality of Life
    • Target Patient's Family to Accelerate Treatment Pathway
    • Websites Are An Essential Tool in Patient & Family Education
    • Provide Communication Tools to Facilitate Patient Conversations
  • Overall Market Outreach
    • Use Dtc to Build Awareness, Complement Professional Campaign
    • A Celebrity Spokesperson Can Help Personalize & Educate
    • Support Advocacy Groups to Expand Disease Awareness
    • UK Launch Spotlight
  • Performance Results
    • Alpha Blocker Revenue for Bph Treatment, 1998-2006
    • Total Sales of Branded Alpha Blockers for Bph, 1998-2006
  • Potential Market Entry Strategies for New Products
  • Appendix
    • Flomax Profile
    • Competitive Landscape at Market Entry
    • Key Definitions
  • about Best Practices, Llc